| 000 | 01442 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517091127.0 | ||
| 264 | 0 | _c20170119 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1755-3768 | ||
| 024 | 7 |
_a10.1111/aos.13042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTheelen, Thomas | |
| 245 | 0 | 0 |
_aMacular fibrosis complicating macular pigment deficient maculopathy in Sjögren-Larsson syndrome. _h[electronic resource] |
| 260 |
_bActa ophthalmologica _cNov 2016 |
||
| 300 |
_ae663-e664 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBevacizumab _xtherapeutic use |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aLutein _xdeficiency |
| 650 | 0 | 4 |
_aMacula Lutea _xpathology |
| 650 | 0 | 4 |
_aSjogren-Larsson Syndrome _xcomplications |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_aZeaxanthins _xdeficiency |
| 700 | 1 | _aCruysberg, Johannes R M | |
| 700 | 1 | _aWillemsen, Michèl A A P | |
| 773 | 0 |
_tActa ophthalmologica _gvol. 94 _gno. 7 _gp. e663-e664 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/aos.13042 _zAvailable from publisher's website |
| 999 |
_c25909643 _d25909643 |
||